Brawn Biotech News

Brawn Biotech board meets May 29

Brawn Biotech Ltd board meets on May 29, 2026 to consider Q4 and FY26 audited results. Trading window closes till May 31.

Brawn Biotech Declares Non-Applicability of SEBI LC Rules

Brawn Biotech Limited confirms it does not qualify as Large Corporate under SEBI framework with NIL outstanding borrowings as on March 31, 2025, making debt security regulations inapplicable.

Brawn Biotech Files Q4FY26 Compliance Certificate

Brawn Biotech Limited submitted its quarterly compliance certificate under SEBI Depositories Regulations for the quarter ended March 31, 2026, confirming proper dematerialisation processes.

Brawn Biotech Appoints New Auditors for FY 2025-26

Brawn Biotech Limited's board approved the appointment of Mr. Viney as Secretarial Auditor and M/s Sahil Pasricha & Associates as Internal Auditors for financial year 2025-26, effective March 25, 2026.

Brawn Biotech Reports Q3 FY26 Financial Results

Brawn Biotech Limited announced Q3 FY26 quarterly results for quarter ended 31st December 2025, showing revenue from operations of ₹5.10 lakhs with comprehensive income of ₹5.00 lakhs.